Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Tivic Health Systems Inc. Common Stock
TIVC | US
0.31
USD0.04
16.74%
TIVC | US
About Tivic Health Systems Inc. Common Stock
Sector
Healthcare
Industry
Medical Devices
Earnings date
30/06/2024
As of date
21/10/2024
Close
0.31
Open
0.27
High
0.33
Low
0.26
Tivic Health Systems Inc. operates as a health technology company focuses on developing and commercializing non-invasive bioelectronic medicine. Its primary product is ClearUP a bioelectronic medicine for the treatment of sinus and nasal congestion pains. The company sells its products on direct-to-consumer channel through its own websites; and platforms such as Amazon.com and Walmart.com as well as to U.S. online retailers such as BestBuy and FSAStore. Tivic Health Systems Inc. was incorporated in 2016 and is headquartered in Hayward California.
View LessTIVC | US
Risk
115.6
Sharpe
-0.53
Luna's Score
37/100
Recommendation
Sell
Luna says (TIVC | US)
What's Working
Value Stock (Price to Book < 3)
What's not Working
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
152.1%1 month
115.6%3 months
176.2%6 months
158.4%Returns
Fundamental Ratios
PE
0.02
Fwd. PE
-
Price to book
0.39
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
0.16
Ent. to rev.
0.68
PEG
-
Other Fundamentals
EBITDA
-6.69M
MarketCap
1.92M
MarketCap(USD)
1.92M
Div. yield
-
Op. margin
-861.43
Erngs. growth
-
Rev. growth
-13.00
Ret. on equity
-183.60
Short ratio
0.26
Short perc.
1.01
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.15
Range1M
0.15
Range3M
0.73
Volumes: Market Activity
Rel. volume
0.96
Price X volume
288.80K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.16 | - | Cheaper |
| Ent. to Revenue | 0.68 | - | Cheaper |
| PE Ratio | 0.02 | 30.41 | Cheaper |
| Price to Book | 0.39 | 6.21 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 176.17 | - | Riskier |
| Debt to Equity | - | -145.53 | - |
| Debt to Assets | - | 0.35 | - |
| Market Cap | 1.92M | - | Emerging |
